GMRE:NYE-Global Medical REIT Inc (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 7.83

Change

-0.18 (-2.25)%

Market Cap

N/A

Volume

0.28M

Analyst Target

USD 14.79
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-29 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

-2.22 (-1.62%)

USD 77.70B
VTR Ventas Inc

-1.23 (-2.02%)

USD 24.71B
DOC Healthpeak Properties Inc

-0.45 (-2.18%)

USD 14.53B
CTRE CareTrust REIT Inc.

-0.96 (-3.53%)

USD 5.04B
AHR American Healthcare REIT, Inc.

-1.18 (-3.98%)

USD 4.42B
NHI National Health Investors Inc

-2.27 (-3.26%)

USD 3.15B
LTC LTC Properties Inc

-0.86 (-2.48%)

USD 1.52B
CHCT Community Healthcare Trust Inc

-0.24 (-1.18%)

USD 0.55B
UHT Universal Health Realty Income..

-0.53 (-1.36%)

USD 0.52B
GMRE-PA Global Medical REIT Inc

N/A

USD 0.41B

ETFs Containing GMRE

KBWY Invesco KBW Premium Yield.. 3.87 % 0.35 %

-0.37 (0%)

USD 0.22B
GYLD Arrow ETF Trust 0.00 % 0.75 %

-0.09 (0%)

USD 0.02B
SDEF 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.42% 67% D+ 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.42% 67% D+ 45% F
Trailing 12 Months  
Capital Gain -22.55% 7% C- 9% A-
Dividend Return 8.31% 79% B- 88% B+
Total Return -14.24% 7% C- 12% F
Trailing 5 Years  
Capital Gain -46.37% 38% F 11% F
Dividend Return 28.36% 69% C- 80% B-
Total Return -18.01% 31% F 16% F
Average Annual (5 Year Horizon)  
Capital Gain -4.70% 36% F 13% F
Dividend Return 1.99% 36% F 31% F
Total Return 6.69% 86% B+ 91% A-
Risk Return Profile  
Volatility (Standard Deviation) 25.11% 43% F 44% F
Risk Adjusted Return 7.94% 36% F 25% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.